Allurion Technologies (ALURD) Free Cash Flow (2022 - 2026)

Allurion Technologies (ALURD) Free Cash Flow (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn 916.00 Mn
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 415.00 Mn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 2.09 Bn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 171.00 Mn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn -21.10 Mn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn 112.00 Mn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 449.00 Mn
8 Smith & Nephew 28.19 Bn 27.62 Bn - -
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn 297.01 Mn
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn -3.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.22 Mn
Mar 31, 2026 -3.22 Mn
Dec 31, 2025 -5.32 Mn
Dec 31, 2025 -5.32 Mn
Sep 30, 2025 -6.53 Mn
Sep 30, 2025 -6.53 Mn
Jun 30, 2025 -7.63 Mn
Jun 30, 2025 -7.63 Mn
Mar 31, 2025 -9.47 Mn
Mar 31, 2025 -9.47 Mn
Dec 31, 2024 -13.27 Mn
Dec 31, 2024 -13.27 Mn
Sep 30, 2024 -12.01 Mn
Sep 30, 2024 -12.01 Mn
Jun 30, 2024 -8.93 Mn
Jun 30, 2024 -8.93 Mn
Mar 31, 2024 -8.70 Mn
Mar 31, 2024 -8.70 Mn
Dec 31, 2023 -22.24 Mn
Dec 31, 2023 -22.24 Mn